Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04611464 · ClinicalTrials.gov registry record
Misoprostol for Spinal Stenosis
A clinical trial of Low Back Pain and Lumbar Spinal Stenosis, sponsored by Dallas VA Medical Center.
- Completed
- Registry status
- 23
- Enrollment target
- 1
- Study location
NCT04611464: Completed study of Low Back Pain and Lumbar Spinal Stenosis, sponsored by Dallas VA Medical Center.
NCT04611464 is a study of Low Back Pain and Lumbar Spinal Stenosis that has completed, run by Dallas VA Medical Center. The registered enrollment target is 23 participants, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04611464, a study of Low Back Pain and Lumbar Spinal Stenosis, has completed, sponsored by Dallas VA Medical Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-group cross-sectional cohort study will enroll approximately 25 patients at the North Texas VA Health Care System (VANTHCS) who have previously received off-label prescriptions of misoprostol for lumbar spinal stenosis for any duration and who are willing to provide verbal and informed consent. Patients will answer a questionnaire regarding pain and functional improvement especially in reference to misoprostol treatment. Patients will also be selected to have their walking tolerance (claudication distance) measured in an outpatient clinic setting to determine the severity of their lumbar spinal stenosis symptoms after having received misoprostol.
Primary Outcome
The SSSQ quantifies severity of symptoms, physical function characteristics, and patient's satisfaction after treatment.
Conditions Studied
Interventions
- DRUG Misoprostol
Study Locations (1)
Texas
- Dallas VA Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-07-11 |
| Est. Completion | 2020-06-01 |
What the finished NCT04611464 record still lists
NCT04611464 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Misoprostol is the first listed.
NCT04611464 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04611464 about?
NCT04611464 is a clinical study titled "Misoprostol for Spinal Stenosis". This single-group cross-sectional cohort study will enroll approximately 25 patients at the North Texas VA Health Care System (VANTHCS) who have previously received off-label prescriptions of misoprostol for lumbar spinal stenosis for any duration and who are willing to provide verbal and informed c...
What is the current status of trial NCT04611464?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2019-07-11. Estimated completion is 2020-06-01.
What conditions does trial NCT04611464 study?
This clinical trial studies the following conditions: Low Back Pain, Lumbar Spinal Stenosis.
What interventions are being tested in trial NCT04611464?
The interventions under investigation include: Misoprostol (DRUG).
Who is sponsoring clinical trial NCT04611464?
This trial is sponsored by Dallas VA Medical Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04611464 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04611464's enrollment target sits among peer trials
23 116th of 122 higher than 7 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Opioid Response to Injections
RECRUITING · Phase 4
-
Erector Spinae Plane Block for Acute Back Pain in the Emergency Department
RECRUITING · NA
-
Evaluation of the Effects of a Rehabilitation Program in Individuals with Spine Pain
RECRUITING
-
The Spine Phenome Project
RECRUITING
-
Overlapping Pain Trajectory Study
RECRUITING
-
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI